1-7 of 7
Ni Chun Tsai, MS, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes

Anthony Stein, Ketevan Gendzekhadze, PhD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Stephen J. Forman, John A. Zaia, MD, David Senitzer, PhD, Ryotaro Nakamura, MD
Journal: Blood
Blood (2014) 124 (21): 669.
https://doi.org/10.1182/blood.V124.21.669.669
Published: 2014
Journal Articles

Hypercvad Induction Chemotherapy Is Associated with Higher Rates of Stem Cell Mobilization Failure in Mantle Cell Lymphoma ( MCL)

Amandeep Salhotra, MD, Shan Yuan, MD, Joycelynne Palmer, PhD, Ibrahim Aldoss, MD, Ni-Chun Tsai, MS MPH, Tanya Paris, Stephen J. Forman, MD, Robert W Chen, MD
Journal: Blood
Blood (2014) 124 (21): 3849.
https://doi.org/10.1182/blood.V124.21.3849.3849
Published: 2014
Journal Articles

Drug Metabolism Gene Polymorphisms Influence Tacrolimus/Sirolimus Blood Levels and Incidence of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Samer K Khaled, MD, Joycelynne Palmer, PhD, Josef Herzog, Tracey Stiller, MS, Ni-Chun Tsai, MS MPH, David Senitzer, PhD, Xueli Liu, PhD, Sandra H. Thomas, PhD, Sepideh Shayani, PharmD, Jeffrey Weitzel, MD, Stephen J. Forman, Ryotaro Nakamura, MD
Journal: Blood
Blood (2014) 124 (21): 2492.
https://doi.org/10.1182/blood.V124.21.2492.2492
Published: 2014
Journal Articles

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

Robert Chen, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Tanya Paris, Leslie Popplewell, MD, Chatchada Karanes, MD, Tanya Siddiqi, MD, Auayporn Nademanee, MD, Ji-Lian Cai, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2013) 122 (21): 3374.
https://doi.org/10.1182/blood.V122.21.3374.3374
Published: 2013
Journal Articles

Pilot Study: Favorable Outcomes with Addition of Topotecan to Busulfan/Melphalan As High-Dose Myeloablative Therapy Followed by Autologous Hematopoietic Cell Transplantation

Joseph Rosenthal, MD, Anna Pawlowska, MD, Jerry Cheng, MD, Steven Kechichian, Debbie Hitt, Mary Suarez, Ni-Chun Tsai, MS MPH, Joycelynne Palmer, PHD
Journal: Blood
Blood (2012) 120 (21): 4553.
https://doi.org/10.1182/blood.V120.21.4553.4553
Published: 2012
Journal Articles

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Anthony Selwyn Stein, MD, Jeffrey Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, MS MPH, Pablo Parker, MD, Len Farol, MD, Ricardo Spielberger, MD, Firoozeh Sahebi, MD, Neil Kogut, MD, Joyce Murata-Collins, PhD, David Senitzer, PhD, Stephen J. Forman, MD
Journal: Blood
Blood (2012) 120 (21): 218.
https://doi.org/10.1182/blood.V120.21.218.218
Published: 2012
Journal Articles

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Amrita Y. Krishnan, MD, Auayporn Nademanee, MD, Andrew Raubitschek, MD, Henry C. Fung, MD, Arturo Molina, MD, David Yamauchi, MD, Peter M. Falk, MD, Ricardo Spielberger, MD, Joycelynne Palmer, PhD, Ni Chun Tsai, MS, MPH, Jeffrey Schriber, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2006) 108 (11): 3043.
https://doi.org/10.1182/blood.V108.11.3043.3043
Published: 2006